Latigo Biotherapeutics, Inc. Common Stock (LTGO) — Financial Flexibility Index
Latigo Biotherapeutics, Inc. Common Stock (LTGO) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of $-21.28 Million (operating CF $-21.28 Million minus capex $0.00) represents 0% of total liabilities ($340.84 Million). Read Latigo Biotherapeutics, Inc. Common Stoc debt and liabilities for a breakdown of total debt and financial obligations.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Latigo Biotherapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Latigo Biotherapeutics, Inc. Common Stock across 2 annual periods. Explore how well can Latigo Biotherapeutics, Inc. Common Stoc service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Financial Flexibility Index for Latigo Biotherapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Latigo Biotherapeutics, Inc. Common Stock. For the full cash flow conversion analysis, see LTGO operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.32x | $-97.42 Million | $-97.56 Million | $307.19 Million | ▲ +5.0% |
| 2024 | -0.33x | $-50.88 Million | $-50.95 Million | $152.46 Million | — |